BioPharma Dive 23 mars 2026 Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
BioPharma Dive 6 mars 2026 Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs
BioPharma Dive 4 févr. 2026 Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan
BioPharma Dive 12 janv. 2026 JPM26: US biotech’s ‘Sputnik moment,’ Pfizer’s obesity ambitions and Bristol Myers’ big year